A cellular-based assay – Quite straightforward, right?
At Pivot Park Screening Centre, we develop and carry out many different assay formats (biochemical, cellular, or biophysical assays). Cellular
Are you looking for lead candidate compounds for your target and do you want your drug discovery program to be more efficient, in terms of both time and cost?
Projects are tailored to your requirements; We provide drug discovery services in the fields of biochemical, biophysical and cellular assay development, lab automation, ultra-High Throughput Screening (uHTS, usually in 1536-well format) and hit-to-lead biological profiling, in order to find novel leads for drug development.
Furthermore all major read-out modalities are available in-house ensuring rapid generation of high-quality hits. As first CRO we integrated Mass Spectrometry (MALDI-TOF MS) into our uHTS system, thus providing you with the opportunity to run label-based and also label-free assays.
You can either bring your own small molecule library or use our 300K IP-free druglike compound library. Our fully automated robot system can handle at least 2 mln. compounds per screen. As a matter of fact, over the past 10 years we have successfully completed more than 150 screening campaigns.
We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community.
In order to help you accelerate drug discovery for a healthier society.
Interested? Get in touch and we’ll help you accelerate your drug discovery.
Pivot Park Sreening Centre is located at Pivot Park in the Netherlands, because it focuses on pharmaceutical R&D. It is a particularly inspiring campus for open innovation in life sciences.
A cellular-based assay – Quite straightforward, right?
At Pivot Park Screening Centre, we develop and carry out many different assay formats (biochemical, cellular, or biophysical assays). Cellular
Bigger and better screening in Oss
The Pivot Park Screening Centre in Oss got off to a flying start thanks to an inheritance from America. The
We started a program to identify novel hits that inhibit the interaction between the viral spike protein subunit S1 and human angiotensin-converting enzyme 2 (hACE2).
Nordic Life Science Days, November 29-30
Meet our experts in Copenhagen, Denmark on November 29-30 at the Nordic Life Science Days.
Is your assay amendable to ultra-High-Throughput Screening?
Seven aspects to consider…
Subscribe to our newsletter
Pivot Park – Banting Building (RE600)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.